Austria has gained an outstanding reputation as a research location in the field of life sciences both as a vibrant hub for science and as a cluster for research-oriented and manufacturing companies. The ABA links international companies with this ecosystem
https://european-biotechnology.com/wp-content/uploads/2024/04/Austria_as_a_Life_Sciences_Hotspot.png540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-09-22 17:58:472024-04-02 15:34:15Austria as a Life Sciences Hotspot
British drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three targets in oncology, neurology and immunology.
Autoimmunity specialist AbolerIS Pharma will use a €27.3m Series A Financing to advance its first-in-class antibody inducing immune tolerance in rheumatoid arthritis into the clinic.
https://european-biotechnology.com/wp-content/uploads/2024/04/AborelS_Pharma.png12982048Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-09-19 07:14:002024-07-09 14:13:38Aboleris Pharma bags €27.3m in Series A Financing
The Cultivated B ist the first company in the world to apply for EU-Novel-Food authorisation of a hotdog made from plant protein and cultivated muscle cells.
https://european-biotechnology.com/wp-content/uploads/2024/04/hot-dog-1238711_1280.jpeg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-09-17 20:59:002025-02-19 11:17:10German company aims for the first EU approval for cell-cultured meat
A Belgian-British research team has identified the human protein underlying necroptosis of human brain cells in Alzheimer’s mice and stopped cell death.
French-US-based investment specialist Lauxera Capital Partners announced today that it has invested €17m in Swedish cell culture company BioLamina AB (BioLamina)
Orano Med SAS and Orbit Discovery Ltd announced a collaboration to develop Peptide Receptor Radionuclide Therapies for cancer cells and develop novel radiopharmaceuticals.
London-based Engitix Ltd has appointed a new Chief Scientific Officer (CSO). Christopher Stevenson, Ph.D. took over the position at the beginning of September.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Chris_Stevenson_kl.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-09-08 09:36:012024-05-24 14:25:56New CSO has started
Eva Schlintl joined the LISAvienna team at the beginning of September. Most recently, she managed the LISA Life Science Austria programme of Austria Wirtschaftsservice Gesellschaft mbH (aws).
https://european-biotechnology.com/wp-content/uploads/2024/04/tk.de_Eva_Schlintl_neu.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-09-08 09:18:262024-05-24 14:24:56LISAvienna welcomes new team member
Austria as a Life Sciences Hotspot
Sponsored PublicationsAustria has gained an outstanding reputation as a research location in the field of life sciences both as a vibrant hub for science and as a cluster for research-oriented and manufacturing companies. The ABA links international companies with this ecosystem
BenevolentAI Ltd inks US$594m partnership with Merck KGaA
Latest NewsBritish drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three targets in oncology, neurology and immunology.
Aboleris Pharma bags €27.3m in Series A Financing
Latest NewsAutoimmunity specialist AbolerIS Pharma will use a €27.3m Series A Financing to advance its first-in-class antibody inducing immune tolerance in rheumatoid arthritis into the clinic.
German company aims for the first EU approval for cell-cultured meat
Latest NewsThe Cultivated B ist the first company in the world to apply for EU-Novel-Food authorisation of a hotdog made from plant protein and cultivated muscle cells.
Researchers stop brain cell death in Alzheimer’s mice
Latest NewsA Belgian-British research team has identified the human protein underlying necroptosis of human brain cells in Alzheimer’s mice and stopped cell death.
Pierre Fabre Laboratories acquires Vertical Bio
Latest NewsFrench pharma company Pierre Fabre Laboratories has baged Vertical Bio to push development of the company’s NSCLC candidate.
C
BioLamina AB bags €19m funding for expansion
Latest NewsFrench-US-based investment specialist Lauxera Capital Partners announced today that it has invested €17m in Swedish cell culture company BioLamina AB (BioLamina)
Radiotherapy R&D partnership
Latest NewsOrano Med SAS and Orbit Discovery Ltd announced a collaboration to develop Peptide Receptor Radionuclide Therapies for cancer cells and develop novel radiopharmaceuticals.
New CSO has started
AppointmentsLondon-based Engitix Ltd has appointed a new Chief Scientific Officer (CSO). Christopher Stevenson, Ph.D. took over the position at the beginning of September.
LISAvienna welcomes new team member
AppointmentsEva Schlintl joined the LISAvienna team at the beginning of September. Most recently, she managed the LISA Life Science Austria programme of Austria Wirtschaftsservice Gesellschaft mbH (aws).